AIM movers: ITM Power selected in Asia and Venture Life sells manufacturing operations

2

Shares in portable oxygen device developer Belluscura (LON: BELL) rebounded 54.6% to 0.85p after Friday’s announcement of a strategic review, but it has still halved over the week. There is a shortage of working capital. There was cash of $1m and $790,000 of debt at the end of April 2025.

ITM Power (LON: ITM) has been selected to supply 300MW of electrolysers to produce green hydrogen for a power plant in Asia Pacific. This project is subject to final investment decision. The share price moved up 16.2% to 41.6p.

Venture Life Group (LON: VLG) is selling its contract development and manufacturing business to Italy based BioDue so that it can focus on its own self care brands. There will also be a ten year manufacturing agreement. The disposal includes some non-core brands and will generate £53m. The remaining business should have annual revenues of £43m and cash to acquire more brands. The prospective 2026 earnings multiple is eight. The share price is 10% higher at 49.5p.

Oriole Resources (LON: ORR) has found 125 gold-bearing intersections from eight holes on the Mbe gold project in Cameroon. The one is intersection for every 21 metres drilled. The results of holes nine to eleven are expected before the end of June. The share price improved 9.18% to 0.217p.

Velocity Composites (LON: VEL) has renewed its contract with BAE Systems for another three years and gained a price increase to cover higher costs. The company provides composite material kits for the F35 and Typhoon. The share price increased 10.6% to 26p.

FALLERS

Late on Friday, organ transplant diagnostics developer Verici Dx (LON: VRCI) published a circular ahead of a general meeting to gain shareholder approval to issue shares on a non-pre-emptive basis. A fundraising is planned, but no share price has been set. The share price slipped 23.1% to 1.25p.

Water remediation technology developer MyCelx Technologies (LON: MYX) reported 2024 figures in line with expectations. Revenues fell from $10.9m to $4.9m, but that was mainly down to the timing of a $5.4m contract. They are expected to recover to $13.5m in 2025 and that could be enough to breakeven. The share price fell 10.9% to 20.5p.

Occupational health services provider Optima Health (LON: OPT) returned to growth in the second half of 2024 and full year are expected to be £105m, which is 5% lower than in the previous year. EBITDA is expected to fall from £18.2m to £17.6m, but pre-tax profit should be flat at £13.4m. Optima Health was demerged from Marlowe last September. Three acquisitions have been made in 2025, and a military contract has been won that starts in 2027. The share price dipped 4.1% to 187p.

Oil condition monitoring equipment supplier Tan Delta Systems (LON: TAN) reported an expected dip in 2024 revenues from £1.46m to £1.22m, while the loss increased from £1.17m to £1.05m. There is £3.1m in the bank. There is a £35m pipeline of potential business. The share price decreased 2.7% to 18p.

FTSE 100 gains in choppy trade as details of US/China trade deal emerge

The FTSE 100 started Monday’s session firmly higher before falling back as details of the US/China trade deal emerged.

US equity futures surged overnight, leading to a strong start for London’s leading index. However, trade became choppy after the terms of a 90-day deal between the US and China hit the wires and raised questions about positioning in the defensively oriented FTSE 100.

Under the terms of the interim agreement, tariffs on Chinese imports to the US will be reduced to 30%, and US imports to China will fall to 10%.

While this is a major improvement to the 145% tariff on Chinese imports and 125% on US imports, it will still make most goods much more expensive than before the Liberation Day announcement and threaten US economic growth.

That said, the willingness of China and the US to sit down and thrash out a deal is a major boost to risk sentiment and signals that further improvements to the terms of their trade relationship could be achieved in the coming months.

“The US-China tariff truce is a tactical pause, not a final deal but for markets, but it’s a meaningful de-escalation,” explained Lale Akoner, global market analyst at eToro.

“While the structural issues remain unresolved, the signal is clear: neither side wants to push trade tensions further. Slashing duties from 145% to 30% (US) and 125% to 10% (China) marks a dramatic de-escalation, likely aimed at calming markets and averting further economic drag. 

“Still, follow-through matters more than headlines. The deal is still short on detail, and it’s unclear what an “acceptable” outcome looks like for either side.”

London’s leading index touched 8,646 in early trade on Monday – the highest point since Trump announced tariffs in early April – but turned negative shortly after the particulars of the US and China deal.

S&P 500 futures remained positive, but gave up ground in the wake of the announcement.

The FTSE 100’s China-focused stocks were at the top of the leaderboard with Glencore, Anglo American and Standard Chartered all surging more than 5%.

However, AstraZeneca weighed on the index with little progress on the plans for US tariffs on pharmaceuticals.

There were also big declines for precious miners Endeavour Mining and Fresnillo as gold prices tanked on the US/China deal.

The FTSE 100 outperformed other major global equity indices such as the S&P 500 during the worst of the trade-induced volatility, so it wouldn’t be a surprise to see the index underperform as deals are made and risk sentiment improves.

Share Tip: McBride Group – trading on some 7.1 times estimated earnings, dropping to 6.7 prospective

We have all got this group’s products somewhere in our homes, although we may not recognise them as being made by the Middleton, Manchester-based McBride Group (LON:MCB). 
The £257m-capitalised business is the leading European manufacturer and supplier of Private Label and Contract Manufactured products for the domestic household and professional cleaning and hygiene markets. 
Share Price Performance 
Over two years ago, I featured the company, with its shares then just 24p, since when they have been as high as 158p. 
Just in 2025, they have been as low as 96.62p (in mid-Ja...

IG Group enjoys higher revenues from Trump-induced volatility

Investment and trading platform firm IG Group revealed the benefits of the Trump-induced market volatility in a short trading statement released on Monday.

The FTSE-250 firm revealed that heightened market volatility, particularly during April, has driven client trading activity well above typical levels.

IG said it expects its full-year revenue and adjusted profit before tax to meet or slightly surpass the upper end of analyst consensus, currently projected at £1.05 billion and £516.3 million respectively.

In April, we explained why trading platforms such as IG always do well during periods of volatility. Dramatic market swings almost always increase trading activity, directly bolstering the revenue for brokers like IG.

IG Group also provided an update on its balance sheet management and announced a new credit facility that is designed to help the group make further acquisitions. IG recently completed the takeover of Freetrade.

IG Group shares were flat at the time of writing after rallying around 20% from post-tariff lows.

Tekcapital’s Guident files for US IPO

Autonomous vehicle technology company Guident has filed for its US IPO as the sector heats up amid the wider adoption of autonomous vehicles across the globe.

The Tekcapital portfolio company announced its intention to list on the NASDAQ at the beginning of the year. Many companies put off their plans to list amid heightened volatility caused by Trump’s trade policies, and today’s announcement comes after a sustained period of improvement in US equity markets.

Guident’s S-1 filing with the SEC has been made confidentially, which allows the company to keep commercially sensitive information private and gives them greater control over the timing of their IPO.

Information related to the IPO will be made public in the run-up to the IPO after a period of review by the SEC.

“The biggest advantage of confidential filings is withholding information from competitors for a few months, compared to a traditional filing that everyone could see,” said Jay Ritter, a finance professor at the University of Florida, to Forbes.

US tech giants, including Uber, Lyft and Airbnb, have opted to use confidential IPO filings in the past.

Tekcapital didn’t share any information relating to the IPO fundraise or valuation in today’s announcement.

“The number of shares to be offered and the price range for the proposed offering have not yet been determined,” the Tekcapital announcement read.

Guident’s IPO filing has been announced against the backdrop of rapid expansion across the autonomous vehicle industry. Notable recent developments include Uber’s investment in WeRide to expand AV taxi operations into 15 more cities globally and Waymo’s plans to add 2,000 more vehicles to its fleet through 2026.

Director deals: Fadel Partners non-executive boosts trading in the shares

New York-based rights management and brand compliance software provider Fadel Partners Inc (LON: FADL) reported its 2024 figures at the end of April and non-executive director Joseph Gruttadauria has been buying shares since then.
He bought an initial 20,000 shares at 70p and then acquired 2,500 shares at 82.5p each and 2,500 shares at 80p each. That takes his stake to 25,000 shares.
Joseph Gruttadauria is chief revenues officer for ERP Maestro, which provides access security and compliance software.
Business
Tarek Fadel founded the business two decades ago and it has two main products. IPM Su...

IFOREX Financial Trading plans £50m flotation

Guernsey-based iFOREX Financial Trading Holdings Ltd has published a registration document ahead of the proposed flotation on the Main Market. The company wants to raise £5m and hopes for a market valuation of £50m.

iFOREX has an online and mobile contact for difference (CFD) trading platform, which it developed itself. Clients can trade in currencies, commodities, indices, cryptocurrencies, shares and exchange traded funds. The majority of trading is via mobile.

There are two regulated subsidiaries. Formula Investment House is based in the British Virgin Islands but operates via Greece. ICFD is based Cyprus and has been licensed on 23 May 2011. This subsidiary is used to accept clients from the European Economic Area.  

The registration document states that clients are able to trade in CFDs linked to underlying instruments and leveraged provided is limited by regulation and the company’s assessment of specific risk. Argentex also insisted that it took appropriate action when it came to risk and this shows that investors should always be aware of the dangers of this type of business.

In the document the company says: “Extreme market movements or events, which the Group is unable to, or fails to promptly manage, could cause a material exposure or risk to the Group”.

Currencies account for 37% of trading and commodities 33%. Commodities include metals, energy and agricultural produce.  

Revenues are generated via a dealing spread on trades. There are also fees on positions held overnight. There can also be gains and losses on client trading positions. The overnight fees can offset some of this risk.

Since 2014, the company has distributed £262m to shareholders. The plan is to pay 50% of earnings as dividends.

In 2024, trading income was $50.1m, slightly higher than in 2023 but well down on the 2022 level of $76.8m. That decline was due to competitiveness and the tightening of spreads, as well as a lower number of transactions. Asia is the biggest contributor to revenues.

In 2022, trading gains were $18.6m and they dropped to $6.24m in 2024.  

In 2024, pre-tax profit was $6m, down from $7.57m in 2023, due higher overheads and interest charges. Management says that was partly due to pre-admission costs.

iFOREX wants to move into new markets and is seeking acquisition opportunities.

AIM weekly movers: Positive trading news for CT Automotive

2

Degradable plastics developer Symphony Environmental Technologies (LON: SYM) has raised £2.5m at 20p/share from Quantum Leap Capital. The subscription will be in two tranches and Quantum Leap Capital will have a 5.26% stake. The subscription price is more than double the market price even after a 123% jump to 7.25p.

Trading in RiverFort Global Opportunities (LON: RGO) shares recommenced following the publication of details of the acquisition of the healthy snacks operations of Aquis-quoted S-Ventures (LON: SVEN) for 466.7 million shares and a £1m placing at 0.75p/share. A loan is being converted into 356.3 million shares. RiverFort will be able to provide cash to grow the business. The company will change its name to Tooru. The share price rebounded 59.1% to 0.35p.

Automotive interior components supplier CT Automotive (LON: CTA) improved margins in 2024 through cost reductions and greater efficiency. That enabled pre-tax profit to edge up from $8.3m to $8.7m even though revenues declined. A rise in pre-tax profit to $10.5m is expected this year. There is uncertainty about US tariffs, but the company can move supply from China to Mexico. Non-exec Nick Timberlake bought 20,000 shares at 27.7p each. The share price improved 55.3% to 36.5p.

Surface Transforms (LON: SCE) chef executive Kevin Johnson bought 10.18 million shares at 0.3757p each. The estate of William Black has been reducing its shareholding, and it is down to 2.45%. The share price recovered 41% to 0.55p.

FALLERS

Trading recommenced in Argentex (LON: AGFX) shares following the financial problems due to taking on too much risk on foreign currency transactions and the recommended bid of 2.49p/share from IFX Payments, which is also providing a facility of up to £20m on top of a £10.5m bridge facility previously provided. The share price slumped 94% to 2.6p.

Seaweed-based animal feed Ocean Harvest Technology (LON: OHT) says first quarter revenues grew 65%, but it remains loss making. Further funds are being sought from investors, but it has not yet secured any commitments. Talks are also ongoing with the secured loan note holders, which may be able to request repayment because of a potential default. There is enough cash until mid-June. The share price dived 76.2% to 1.25p.

Peel Hunt continues to reduce its shareholding in the in content advertising company Mirriad Advertising (LON: MIRI). It has fallen from 14.1% to 4.14%. The company continues to seek funding so that it can stave off the need for going into administration. Discussions are ongoing with potential investors. The share price slipped a further 35.7% to 0.027p.

Film and TV subtitling and dubbing services provider Zoo Digital (LON: ZOO) says work is coming through more slowly than expected. The timing of projects remains uncertain. Revenues for the year to March 2025 have been reduced by 3% to $49.4m and the loss increased to $7.4m. A 23% cut in forecast 2025-26 revenues to $42.5m means that Zoo Digital could continue to be loss making. Even so, net cash could improve from $2.6m to $3m. Rob Pursell has been appointed as finance director. The share price declined 23.7% to 9.25p.

Aquis weekly movers: Smarter Web Company premium fundraising

Recent Acquis new entrant Smarter Web Company (LON: SWC) has launched a WRAP retail offer and accelerated bookbuild raising £2.24m at 16p/share. Prior to flotation the web design and online marketing company raised £1m at 2.5p/share. That cash has been invested in Bitcoin. So far £760,000 has been spent on 10.6 Bitcoin at £71,356 each. The cash will eventually be used for expansion and acquisitions. The share price jumped 363% to 22p.

Brompton Asset Management has raised its shareholding in Global Connectivity (LON: GCON) from 14.8% to 18.6%. The share price recovered 30.8% to 0.85p.

Wishbone Gold (LON: WSBN) has identified eleven new gold targets at the Crescent gold project in the Mosquito Creek area of Western Australia. The company has appointed Apex Geoscience Consultants to manage the ground exploration and drilling at the Red Setter Dome. Hot Rocks Investments (LON: HRIP) has reduced its stake below 3%. The Wishbone Gold share price increased 14.7% to 0.195p.

In 2024, Newbury Racecourse (LON: NYR) increased revenues by 16% to £22m and pre-tax profit improved from £720,000 to £1.1m. There were 30 race days, two more than the previous year. A final dividend of 6p/share was announced. Cash was £7.5m at the end of 2024. The share price rose 10.8% to 565p.

Valereum (LON: VLRM) raised £500,000 at 4p/share. This will help to fund the launch and scaling up digital asset services. The share price is 10.5% higher at 5.25p.

Marula Mining (LON: MARU) has completed wet commissioning of the Kilifi manganese processing plant in Kenya. The first manganese sales should be in May. The latest exploration of Kilifi is focused on specific target areas to assess the suitability of ores for processing. The share price improved 10.3% to 4p.

Ormonde Mining (LON: ORM) investee company TRU Precious Metals has commenced drilling at the Gold Rose project in the central Newfoundland gold belt. The share price edged up 8.7% to 0.125p.

FALLERS

NYCE International (LON: NYCE), formerly ChallengerX, has established a gaming advisory committee, including Farzad Peyman, Harmen Brenninkmeijer, Richard Clarke and Simon French. The share price fell 8.57% to 0.16p.

BWA Group (LON: BWAP) says shallow drilling has been completed at the 90%-owned Dehane 1 mineral sands project in Cameroon. This shows significant accumulations of heavy mineral sands. Total heavy mineral sands grades are up to 4.7% over eight metres thickness. Significant areas remain untested. The share price has decreased 7.5% to 0.185p.

Ananda Pharma (LON: ANA) says ex-GW Pharmaceuticals executive Giles Moss is an advisor. He will provide expertise in regulatory approvals. GW Pharmaceuticals was acquired by Jazz Pharmaceuticals. The share price slipped 6.25% to 0.375p.

AIM movers: Belluscura strategic review and potential Brave Bison purchase from Centaur Media

21

Trading in RiverFort Global Opportunities (LON: RGO) shares recommenced following the publication of details of the acquisition of the healthy snacks operations of Aquis-quoted S-Ventures (LON: SVEN) for 466.7 million shares and a £1m placing at 0.75p/share. A loan is being converted into 356.3 million shares. RiverFort will be able to provide cash to grow the business. The company will change its name to Tooru. The share price jumped 70.5% to 0.375p.

Tracarta has taken a 4.15% stake in gas and clean energy projects developer Coro Energy (LON: CORO). The share price rose 9.3% to 1.175p.

Building and plumbing products distributor Lords Group Trading (LON: LORD) shares continue to rise following yesterday’s 2024 results announcement and trading statement. First quarter like-for-like growth is 11% in merchanting and 22% in plumbing and heating. That does compare with a weak period of the previous year. Property disposals have reduced borrowings. The share price improved 6.78% to 31.5p.

FALLERS

Medical device developer Belluscura (LON: BELL) says US tariffs on portable oxygen containers remain at zero. There were record sales of X-PLOR portable oxygen products in April. The DISCOV-R will be launched in the third quarter. The problem is a shortage of working capital. There was cash of $1m and $790,000 of debt at the end of April 2025. A strategic review has been launched. The share price slumped 22.2% to 0.525p.

Peel Hunt continues to reduce its shareholding in the in content advertising company Mirriad Advertising (LON: MIRI). It has fallen from 14.1% to 4.14%. The company continues to seek funding so that it can stave off the need for going into administration. Discussions are ongoing with potential investor. The share price fell 15.4% to 0.0275p.

Ardonagh Group is selling 1.6 million shares in BP Marsh (LON: BPM) at 630p each via a bookbuild undertaken by Panmure Liberum. Ardonagh would still have a 15.6% stake. The share price declined 7.04% to 660p.

Physiomics (LON: PYC) has been awarded a £67,500 contract with a new UK client. It will apply population Pharmacokinetic (PK) modelling techniques using Phase 1 data to inform the Phase 2 study of a small molecule designed to treat rheumatoid arthritis. The share price slipped 5.68% to 0.415p.

Digital media company Brave Bison (LON: BBSN) confirms that it is in exclusive talks to buy MiniMBA from Centaur Media (LON: CAU) for £19m. This is an elearning provider for marketing professionals. This would be part funded by a placing and a strategic investment of £4m by MiniMBA founder Mark Ritson. This deal would add £3.5m to group EBITDA taking it to £8m. The share price originally rose but is down 1.96% to 2.5p.